Cost-effectiveness of midostaurin in the treatment of acute myeloid leukemia with the FLT3 mutation in Spain

  1. Arenaza, A.
  2. Diez, R.
  3. Esteve, J.
  4. Di Nicolantonio, R.
  5. Gostkorzewicz, J.
  6. Martínez, C.
  7. Llinàs, D.M.
  8. Martinez-Lopez, J.
  9. Montesinos, P.
  10. Moure-Fernández, A.
  11. Sierra, J.
  12. Vinent, J.L.
Journal:
ClinicoEconomics and Outcomes Research

ISSN: 1178-6981

Year of publication: 2019

Volume: 11

Pages: 683-694

Type: Article

DOI: 10.2147/CEOR.S222879 GOOGLE SCHOLAR lock_openOpen access editor